Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers

被引：0
|
作者：
Liam, C. K. [1 ]
Yew, C. Y. [1 ]
Pang, Y. K. [1 ]
Wong, C. K. [1 ]
Poh, M. E. [1 ]
Tan, J. L. [1 ]
Soo, C. I. [1 ]
Loh, T. C. [1 ]
Chin, K. K. [1 ]
Munusamy, V. [1 ]
Ibrahim, N. H. [1 ]
机构：
[1] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
EGFR mutations; PD-L1; expression; smoking status;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P57.09
引用
收藏
页码：S1141 / S1142
页数：2
相关论文
共 50 条
  • [21] PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
    Jiang, Liyan
    Su, Xinying
    Zhang, Tianwei
    Yin, Xiaolu
    Zhang, Meizhuo
    Fu, Haihua
    Han, Hulin
    Sun, Yun
    Dong, Lili
    Qian, Jialin
    Xu, Yanhua
    Fu, Xuan
    Gavine, Paul R.
    Zhou, Yanbin
    Tian, Kun
    Huang, Jiaqi
    Shen, Dong
    Jiang, Haiyi
    Yao, Yihong
    Han, Baohui
    Gu, Yi
    ONCOTARGET, 2017, 8 (16) : 26845 - 26857
  • [22] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [23] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [24] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [25] Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers
    Lee, Joo Young
    Na, Im Il
    Jang, Seung-Hun
    Hwang, Yong Il
    Choe, Du Hwan
    Kim, Cheol Hyeon
    Baek, HeeJong
    JOURNAL OF THORACIC DISEASE, 2013, 5 (06) : 758 - 763
  • [26] Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer
    Yang, Ching-Yao
    Lin, Mong-Wei
    Chang, Yih-Leong
    Wu, Chen-Tu
    CANCER BIOMARKERS, 2018, 21 (01) : 211 - 220
  • [27] Non-small cell lung cancer in never smokers: a clinical entity to be identified
    Santoro, Ilka Lopes
    Ramos, Roberta Pulcheri
    Franceschini, Juliana
    Jamnik, Sergio
    Godoy Fernandes, Ana Luisa
    CLINICS, 2011, 66 (11) : 1873 - 1877
  • [28] Advanced non-small cell lung cancer in never smokers: An institutional experience
    Stalin, B.
    Gundeti, S.
    Kumar, A. K.
    Lakshmi, M.
    Srinivas, L. M.
    ANNALS OF ONCOLOGY, 2017, 28 : 138 - 138
  • [29] Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Gainor, J. F.
    Rizvi, H.
    Aguilar, E. Jimenez
    Skoulidis, F.
    Yeap, B. Y.
    Naidoo, J.
    Khosrowjerdi, S.
    Mooradian, M.
    Lydon, C.
    Illei, P.
    Zhang, J.
    Peterson, R.
    Ricciuti, B.
    Nishino, M.
    Roth, J. A.
    Grishman, J.
    Anderson, D.
    Little, B. P.
    Carter, B. W.
    Arbour, K.
    Sauter, J. L.
    Mino-Kenudson, M.
    Heymach, J., V
    Digumarthy, S.
    Shaw, A. T.
    Awad, M. M.
    Hellmann, M. D.
    ANNALS OF ONCOLOGY, 2020, 31 (03) : 404 - 411
  • [30] PD-L1 expression in different samples of non-small cell lung cancer
    Kovacevic, M.
    Kern, I.
    VIRCHOWS ARCHIV, 2017, 471 : S104 - S104
12345